For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) closed the day trading at $4.26 down -8.78% from the previous closing price of $4.67. In other words, the price has decreased by -$8.78 from its previous closing price. On the day, 1.43 million shares were traded. VNDA stock price reached its highest trading level at $4.43 during the session, while it also had its lowest trading level at $4.1848.
Ratios:
For a better understanding of VNDA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.91 and its Current Ratio is at 3.93. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on October 31, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On July 11, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.
Jefferies Downgraded its Buy to Hold on February 25, 2022, whereas the target price for the stock was revised from $24 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 13 ’25 when Mitchell Stephen Ray sold 7,000 shares for $4.59 per share. The transaction valued at 32,130 led to the insider holds 97,082 shares of the business.
Mitchell Stephen Ray bought 7,000 shares of VNDA for $32,159 on Jun 13 ’25. On May 21 ’25, another insider, Polymeropoulos Mihael Hristos, who serves as the President and CEO of the company, bought 10,000 shares for $4.40 each. As a result, the insider paid 43,995 and bolstered with 2,325,731 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VNDA now has a Market Capitalization of 251060976 and an Enterprise Value of -53938968. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.25 while its Price-to-Book (P/B) ratio in mrq is 0.49. Its current Enterprise Value per Revenue stands at -0.268 whereas that against EBITDA is 0.835.
Stock Price History:
The Beta on a monthly basis for VNDA is 0.73, which has changed by -0.21111113 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, VNDA has reached a high of $5.99, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is -7.82%, while the 200-Day Moving Average is calculated to be -8.11%.
Shares Statistics:
Over the past 3-months, VNDA traded about 470.54K shares per day on average, while over the past 10 days, VNDA traded about 548030 shares per day. A total of 58.93M shares are outstanding, with a floating share count of 54.89M. Insiders hold about 6.87% of the company’s shares, while institutions hold 77.46% stake in the company. Shares short for VNDA as of 1752537600 were 4594701 with a Short Ratio of 9.76, compared to 1749772800 on 4726102. Therefore, it implies a Short% of Shares Outstanding of 4594701 and a Short% of Float of 8.09.
